Ai Kanda, Nagisa Nomoto, Ken Ebihara, Yoshitaka Iwazu, Tetsu Akimoto, Yukihiko Nakajima, Akira Shimada. Two long-term WAGR syndrome survivors: The importance of managing complications. Pediatrics international : official journal of the Japan Pediatric Society. 2025. 67. 1. e15864
Yushi Hirota, Yasumasa Kakei, Junta Imai, Hideki Katagiri, Ken Ebihara, Jun Wada, Junichi Suzuki, Tatsuhiko Urakami, Takashi Omori, Wataru Ogawa. A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02). Journal of diabetes investigation. 2024. 15. 9. 1211-1219
Yushi Hirota, Yasumasa Kakei, Junta Imai, Hideki Katagiri, Ken Ebihara, Jun Wada, Junichi Suzuki, Tatsuhiko Urakami, Takashi Omori, Wataru Ogawa. A Multicenter, Open-Label, Single-Arm Trial of the Efficacy and Safety of Empagliflozin Treatment for Refractory Diabetes Mellitus with Insulin Resistance (EMPIRE-01). Diabetes therapy : research, treatment and education of diabetes and related disorders. 2024. 15. 2. 533-545
Momoe Sakurai, Tetsuji Wakabayashi, Yasuyuki Kondo, Eriko Ikeda, Koichi Watanabe, Akihito Takei, Hiroaki Okazaki, Kenta Okada, Ken Ebihara, Nobuyuki Kakiuchi, et al. A case of vasoactive intestinal peptide-secreting tumor (VIPoma) arising from MEN1 inactivation which recurred 15 years after the initial resection. Endocrine journal. 2023. 70. 6. 573-579
Daisuke Suto, Ken Ebihara, San-E Ishikawa. Transit analysis of thyroid antibodies in graves' disease following painless thyroiditis: a case report. Annals of medicine and surgery (2012). 2023. 85. 5. 2119-2122
